Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq.

Yin Q, Strong MJ, Zhuang Y, Flemington EK, Kaminski N, de Andrade JA, Lasky JA.

BMC Pulm Med. 2020 Apr 3;20(1):81. doi: 10.1186/s12890-020-1114-1.

2.

Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.

Fan Y, Bender SD, Conoscenti CS, Davidson-Ray L, Cowper PA, Palmer SM, de Andrade JA; IPF-PRO Registry Investigators.

Chest. 2020 Jan 29. pii: S0012-3692(20)30133-1. doi: 10.1016/j.chest.2019.12.041. [Epub ahead of print]

3.

Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.

Kulkarni T, Yuan K, Tran-Nguyen TK, Kim YI, de Andrade JA, Luckhardt T, Valentine VG, Kass DJ, Duncan SR.

PLoS One. 2019 Oct 4;14(10):e0221905. doi: 10.1371/journal.pone.0221905. eCollection 2019.

4.

Home-Based Pulmonary Rehabilitation for Patients With Idiopathic Pulmonary Fibrosis: A PILOT STUDY.

Yuen HK, Lowman JD, Oster RA, de Andrade JA.

J Cardiopulm Rehabil Prev. 2019 Jul;39(4):281-284. doi: 10.1097/HCR.0000000000000418.

PMID:
31241519
5.

Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.

Barnes JW, Duncan D, Helton S, Hutcheson S, Kurundkar D, Logsdon NJ, Locy M, Garth J, Denson R, Farver C, Vo HT, King G, Kentrup D, Faul C, Kulkarni T, De Andrade JA, Yu Z, Matalon S, Thannickal VJ, Krick S.

Am J Physiol Lung Cell Mol Physiol. 2019 Jul 1;317(1):L141-L154. doi: 10.1152/ajplung.00246.2018. Epub 2019 May 1.

PMID:
31042083
6.

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.

7.

Patient Registries in Idiopathic Pulmonary Fibrosis.

Culver DA, Behr J, Belperio JA, Corte TJ, de Andrade JA, Flaherty KR, Gulati M, Huie TJ, Lancaster LH, Roman J, Ryerson CJ, Kim HJ.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):160-167. doi: 10.1164/rccm.201902-0431CI. Review.

8.

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis.

Lancaster LH, de Andrade JA, Zibrak JD, Padilla ML, Albera C, Nathan SD, Wijsenbeek MS, Stauffer JL, Kirchgaessler KU, Costabel U.

Eur Respir Rev. 2017 Dec 6;26(146). pii: 170057. doi: 10.1183/16000617.0057-2017. Print 2017 Dec 31. Review.

9.

Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis.

Li FJ, Surolia R, Li H, Wang Z, Kulkarni T, Liu G, de Andrade JA, Kass DJ, Thannickal VJ, Duncan SR, Antony VB.

J Immunol. 2017 Sep 1;199(5):1596-1605. doi: 10.4049/jimmunol.1700473. Epub 2017 Jul 28.

10.

More than meets the eye: IgG4-related disease presenting as isolated interstitial lung disease.

Jagpal A, Crowe DR, de Andrade JA, Del Pilar Acosta Lara M, Navarro-Millan I.

Rheumatology (Oxford). 2017 Sep 1;56(9):1630-1631. doi: 10.1093/rheumatology/kex146. No abstract available.

PMID:
28582539
11.

What Is in a Pattern? That Which We Call Idiopathic Pulmonary Fibrosis by Any Other Pattern Would Behave Alike!

de Andrade JA, Luckhardt T.

Am J Respir Crit Care Med. 2017 Jan 1;195(1):10-12. doi: 10.1164/rccm.201606-1277ED. No abstract available.

12.

A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival.

Kulkarni T, Willoughby J, Acosta Lara Mdel P, Kim YI, Ramachandran R, Alexander CB, Luckhardt T, Thannickal VJ, de Andrade JA.

Respir Med. 2016 Jun;115:33-8. doi: 10.1016/j.rmed.2016.04.010. Epub 2016 Apr 20.

13.

Heart fossilization is possible and informs the evolution of cardiac outflow tract in vertebrates.

Maldanis L, Carvalho M, Almeida MR, Freitas FI, de Andrade JA, Nunes RS, Rochitte CE, Poppi RJ, Freitas RO, Rodrigues F, Siljeström S, Lima FA, Galante D, Carvalho IS, Perez CA, de Carvalho MR, Bettini J, Fernandez V, Xavier-Neto J.

Elife. 2016 Apr 19;5:e14698. doi: 10.7554/eLife.14698.

14.

Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.

Pennathur S, Vivekanandan-Giri A, Locy ML, Kulkarni T, Zhi D, Zeng L, Byun J, de Andrade JA, Thannickal VJ.

Am J Respir Crit Care Med. 2016 Apr 15;193(8):861-8. doi: 10.1164/rccm.201505-0992OC.

15.

Development and maintenance of a biospecimen repository for clinical samples derived from pulmonary patients.

Schwiebert LM, Estell K, Meadows T, Thannickal VJ, Rowe S, Sorscher EJ, Harris WT, Gaggar A, Dransfield M, de Andrade JA.

Clin Transl Sci. 2014 Aug;7(4):336-41. doi: 10.1111/cts.12161. Epub 2014 May 29.

16.

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G.

N Engl J Med. 2014 May 29;370(22):2093-101. doi: 10.1056/NEJMoa1401739. Epub 2014 May 18.

17.

The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis.

de Andrade JAA, Gayer CRM, Nogueira NPA, Paes MC, Bastos VLFC, Neto JDCB, Alves SC Jr, Coelho RM, da Cunha MGAT, Gomes RN, Águila MB, Mandarim-de-Lacerda CA, Bozza PT, da Cunha S.

J Inflamm (Lond). 2014 Apr 24;11:11. doi: 10.1186/1476-9255-11-11. eCollection 2014.

18.

Idiopathic pulmonary fibrosis.

Zolak JS, de Andrade JA.

Immunol Allergy Clin North Am. 2012 Nov;32(4):473-85. doi: 10.1016/j.iac.2012.08.006. Epub 2012 Sep 14. Review.

PMID:
23102062
19.

Innovative approaches to the therapy of fibrosis.

de Andrade JA, Thannickal VJ.

Curr Opin Rheumatol. 2009 Nov;21(6):649-55. doi: 10.1097/BOR.0b013e328330da9b. Review.

20.

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.

King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):75-81. Epub 2007 Sep 27.

PMID:
17901413
21.

Thoughts on the diagnosis and management of interstitial lung diseases.

de Andrade JA.

South Med J. 2007 Jun;100(6):555-6. No abstract available.

PMID:
17591306
22.

Acute diarrhea and malnutrition: lethality risk in hospitalized infants.

Fagundes-Neto U, de Andrade JA.

J Am Coll Nutr. 1999 Aug;18(4):303-8.

PMID:
12038472
23.

Association of reactive nitrogen species metabolites, myeloperoxidase, and airway inflammation in lung transplants.

de Andrade JA, Christie JD, Alexander CB, Young KR, McGiffin DC, Zorn GL, Jackson RM.

J Investig Med. 2001 Mar;49(2):166-72. doi: 10.2310/6650.2001.34043.

PMID:
11288757
24.

Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts.

De Andrade JA, Crow JP, Viera L, Bruce Alexander C, Randall Young K, McGiffin DC, Zorn GL, Zhu S, Matalon S, Jackson RM.

Am J Respir Crit Care Med. 2000 Jun;161(6):2035-42.

PMID:
10852785
25.

[Lethality in hospitalized infants with acute diarrhea: risk factors associated with death].

de Andrade JA, de Oliveira JO, Fagundes Neto U.

Rev Assoc Med Bras (1992). 1999 Apr-Jun;45(2):121-7. Portuguese.

PMID:
10413914
26.

[Mortality in breast-fed infants with persistent diarrhea: risk factors associated with death].

de Andrade JA, Gomes TA, Fagundes-Neto U.

Arq Gastroenterol. 1998 Jan-Mar;35(1):62-8. Portuguese.

PMID:
9711316
27.

Basidiobolomycosis: a case report.

Bittencourt AL, Arruda SM, de Andrade JA, Carvalho EM.

Pediatr Dermatol. 1991 Dec;8(4):325-8.

PMID:
1792208
28.

[Serologic diagnosis of human strongyloidiasis using an immunoenzymatic method].

Brasil R, Badaró R, de Andrade JA, de Andrade TM, Carvalho EM.

Rev Soc Bras Med Trop. 1988 Jul-Sep;21(3):139-43. Portuguese. No abstract available.

PMID:
3254568
29.

[Basidiobolomycosis. Report of a case with unusual aspects].

Bittencourt AL, de Andrade JA, de Carvalho EM.

Rev Inst Med Trop Sao Paulo. 1987 Nov-Dec;29(6):381-4. Portuguese. No abstract available.

PMID:
3454485
30.

[Uncommon aspects of infantile paracoccidioidomycosis].

Bittencourt AL, de Andrade JA, Carvalho EM, Badaró FS, Miranda JS.

Rev Soc Bras Med Trop. 1987 Oct-Dec;20(4):223-4. Review. Portuguese. No abstract available.

PMID:
3333880
31.

[Survey on paracoccidioidin in a population of Bahia (Brazil)].

de Andrade JA, de Andrade TM, Lacaz Cda S, Rodrigues MC, Preuss M, Lorenço R, Badaró R.

Rev Inst Med Trop Sao Paulo. 1984 Jan-Feb;26(1):1-6. Portuguese. No abstract available.

PMID:
6611574
32.

[Hypersensitivity of delayed type in visceral leishmaniasis].

de Andrade TM, Teixeira R, de Andrade JA, Pereira C, de Carvalho Filho EM.

Rev Inst Med Trop Sao Paulo. 1982 Sep-Oct;24(5):298-302. Portuguese. No abstract available.

PMID:
7167708

Supplemental Content

Loading ...
Support Center